In addition, Metabolic dysfunction, including inflammation, insulin resistance, hypothalamic–pituitary–adrenal (HPA) axis dysregulation and central leptin resistance, have emerged as key risks to depression and anxiety development (7, 29, 30). Here, LEP is linked to depressive symptom measurement.